Last Updated: July 28, 2026

Patent: 10,485,884

✉ Email this page to a colleague

Summary for Patent: 10,485,884

Title:	RNA formulation for immunotherapy
Abstract:	The present invention is in the field of immunotherapy, in particular tumor immunotherapy. The present invention provides pharmaceutical formulations for delivering RNA to antigen presenting cells such as dendrite cells (DCs) in the spleen after systemic administration. In particular, the formulations described herein enable to induce an immune response after systemic administration of antigen-coding RNA.
Inventor(s):	Ugur Sahin, Heinrich Haas, Sebastian Kreiter, Mustafa Diken, Daniel Fritz, Martin Meng, Lena Mareen Kranz, Kerstin Reuter
Assignee:	TRON Translationale Onkologie an der Universitaetsmedizin der Johannes Gutenberg Universitaet Mainz gGmbH , Biontech SE
Application Number:	US14/388,192
Patent Claims:	see list of patent claims

Details for Patent 10,485,884

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Biontech Manufacturing Gmbh	COMIRNATY	covid-19 vaccine, mrna	For Injection	125742	August 23, 2021	⤷ Start Trial	2033-03-25
Biontech Manufacturing Gmbh	COMIRNATY	covid-19 vaccine, mrna	For Injection	125742	September 11, 2023	⤷ Start Trial	2033-03-25
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,485,884

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2013143555	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2013143683	⤷ Start Trial
United States of America	11559587	⤷ Start Trial
United States of America	2015086612	⤷ Start Trial
United States of America	2020085974	⤷ Start Trial
United States of America	2023226217	⤷ Start Trial
Turkey	201904758	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.